Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration. 2023

Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.

In multiple sclerosis, spontaneous remyelination is generally incomplete and heterogeneous across patients. A high heterogeneity in remyelination may also exist across lesions within the same individual, suggesting the presence of local factors interfering with myelin regeneration. In this study we explored in vivo the regional distribution of myelin repair and investigated its relationship with neurodegeneration. We first took advantage of the myelin binding property of the amyloid radiotracer 11C-PiB to conduct a longitudinal 11C-PiB PET study in an original cohort of 19 participants with a relapsing-remitting form of multiple sclerosis, followed-up over a period of 1-4 months. We then replicated our results on an independent cohort of 40 people with multiple sclerosis followed-up over 1 year with magnetization transfer imaging, an MRI metrics sensitive to myelin content. For each imaging method, voxel-wise maps of myelin content changes were generated according to modality-specific thresholds. We demonstrated a selective failure of remyelination in periventricular white matter lesions of people with multiple sclerosis in both cohorts. In both the original and the replication cohort, we estimated that the probability of demyelinated voxels to remyelinate over the follow-up increased significantly as a function of the distance from ventricular CSF. Enlarged choroid plexus, a recently discovered biomarker linked to neuroinflammation, was found to be associated with the periventricular failure of remyelination in the two cohorts (r = -0.79, P = 0.0018; r = -0.40, P = 0.045, respectively), suggesting a role of the brain-CSF barrier in affecting myelin repair in surrounding tissues. In both cohorts, the failure of remyelination in periventricular white matter lesions was associated with lower thalamic volume (r = 0.86, P < 0.0001; r = 0.33; P = 0.069, respectively), an imaging marker of neurodegeneration. Interestingly, we also showed an association between the periventricular failure of remyelination and regional cortical atrophy that was mediated by the number of cortex-derived tracts passing through periventricular white matter lesions, especially in patients at the relapsing-remitting stage. Our findings demonstrate that lesion proximity to ventricles is associated with a failure of myelin repair and support the hypothesis that a selective periventricular remyelination failure in combination with the large number of tracts connecting periventricular lesions with cortical areas is a key mechanism contributing to cortical damage in multiple sclerosis.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009186 Myelin Sheath The lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem. Myelin,Myelin Sheaths,Sheath, Myelin,Sheaths, Myelin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074586 Remyelination The reforming of the MYELIN SHEATH around AXONS following loss due to injury or DEMYELINATING DISEASES. Remyelinations
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D066127 White Matter The region of CENTRAL NERVOUS SYSTEM that appears lighter in color than the other type, GRAY MATTER. It mainly consists of MYELINATED NERVE FIBERS and contains few neuronal cell bodies or DENDRITES. Cerebellar White Matter,Cerebellar White Matters,Matter, Cerebellar White,Matter, White,Matters, Cerebellar White,Matters, White,White Matter, Cerebellar,White Matters,White Matters, Cerebellar

Related Publications

Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
August 2019, Cells,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
January 2017, Advances in experimental medicine and biology,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
November 1996, Multiple sclerosis (Houndmills, Basingstoke, England),
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
January 2013, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
September 2015, Nihon rinsho. Japanese journal of clinical medicine,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
May 2024, Multiple sclerosis and related disorders,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
March 2012, Histology and histopathology,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
April 1997, Multiple sclerosis (Houndmills, Basingstoke, England),
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
February 2003, Journal of the neurological sciences,
Matteo Tonietto, and Emilie Poirion, and Andrea Lazzarotto, and Vito Ricigliano, and Caroline Papeix, and Michel Bottlaender, and Benedetta Bodini, and Bruno Stankoff
January 2009, Progress in brain research,
Copied contents to your clipboard!